State of Biosimilars in 2023 and Looking Ahead to 2024
As 2023 draws to a close, the world of pharmaceuticals is abuzz with the transformative potential of biosimilars. Unlike traditional generic drugs, which are exact replicas of small-molecule branded medications, biosimilars are near-copies of complex biologic drugs produced by different manufacturers.
The burgeoning biosimilar market in the U.S. is
